Cognitive Improvement After Multi-Domain Lifestyle Interventions in an APOE ɛ4 Homozygous Carrier with Mild Cognitive Impairment: A Case Report and Literature Review
- PMID: 35988223
- DOI: 10.3233/JAD-220374
Cognitive Improvement After Multi-Domain Lifestyle Interventions in an APOE ɛ4 Homozygous Carrier with Mild Cognitive Impairment: A Case Report and Literature Review
Abstract
Alzheimer's disease (AD) is a degenerative disease of the central nervous system with insidious onset and chronic progression. The pathogenesis of AD is complex, which is currently considered to be the result of the interaction between genetic and environmental factors. The APOE ɛ4 is the strongest genetic risk factor for sporadic AD and a risk factor for progression from mild cognitive impairment (MCI) to AD. So far, no effective drugs have been found for the progression of MCI. However, the effects of nonpharmacological interventions such as nutrition, cognitive, and physical exercises on early AD have received increasing attention. We followed up cognitive assessment scales, Aβ-PET and MRI examination of a patient with MCI for 4 years, who carried APOE ɛ4 homozygous with a clear family history. After 4 years of multi-domain lifestyle interventions including nutrition, socialization, and physical exercises, the patient's cognitive function, especially memory function, improved significantly. Intracerebral amyloid deposition was decreased, and hippocampal atrophy improved. Based on this case, this study reviewed and discussed the interaction of APOE ɛ4 with the environment in AD research in recent years, as well as the impact and mechanisms of non-pharmaceutical multi-domain lifestyle interventions on MCI or early AD. Both the literature review and this case showed that multi-domain lifestyle interventions may reduce the risk of disease progression by reducing Aβ deposition in the brain and other different pathologic mechanisms, which offers promise in brain amyloid-positivity or APOE ɛ4 carriers.
Keywords: APOE; Alzheimer’s disease; diet; genetic risk effect; mild cognitive impairment; nutrition; physical activities; social contacts.
Similar articles
-
A Multi-Cohort Study of ApoE ɛ4 and Amyloid-β Effects on the Hippocampus in Alzheimer's Disease.J Alzheimers Dis. 2017;56(3):1159-1174. doi: 10.3233/JAD-161097. J Alzheimers Dis. 2017. PMID: 28157104 Free PMC article.
-
18F-AV45 PET and MRI Reveal the Influencing Factors of Alzheimer's Disease Biomarkers in Subjective Cognitive Decline Population.J Alzheimers Dis. 2023;93(2):585-594. doi: 10.3233/JAD-221251. J Alzheimers Dis. 2023. PMID: 37066915
-
Topographical APOE ɛ4 Genotype Influence on Cerebral Metabolism in the Continuum of Alzheimer's Disease: Amyloid Burden Adjusted Analysis.J Alzheimers Dis. 2016 Sep 6;54(2):559-68. doi: 10.3233/JAD-160395. J Alzheimers Dis. 2016. PMID: 27567846
-
Subjective Cognitive Decline and APOE ɛ4: A Systematic Review.J Alzheimers Dis. 2018;65(1):303-320. doi: 10.3233/JAD-180248. J Alzheimers Dis. 2018. PMID: 30040718
-
Effect of Apolipoprotein E ɛ4 Carrier Status on Cognitive Response to Acetylcholinesterase Inhibitors in Patients with Alzheimer's Disease: A Systematic Review and Meta-Analysis.Dement Geriatr Cogn Disord. 2018;45(5-6):335-352. doi: 10.1159/000490175. Epub 2018 Jul 24. Dement Geriatr Cogn Disord. 2018. PMID: 30041236
Cited by
-
Chanwuyi Lifestyle Medicine Program Improves Memory and Executive Functions of Older Adults With Mild Cognitive Impairment.Am J Alzheimers Dis Other Demen. 2024 Jan-Dec;39:15333175241255744. doi: 10.1177/15333175241255744. Am J Alzheimers Dis Other Demen. 2024. PMID: 38764310 Free PMC article. Clinical Trial.
-
Association of Unhealthy Lifestyle and Genetic Risk Factors With Mild Cognitive Impairment in Chinese Older Adults.JAMA Netw Open. 2023 Jul 3;6(7):e2324031. doi: 10.1001/jamanetworkopen.2023.24031. JAMA Netw Open. 2023. PMID: 37462970 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous